Chevy Chase Trust Holdings LLC increased its holdings in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) by 5.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 223,581 shares of the company's stock after acquiring an additional 12,478 shares during the quarter. Chevy Chase Trust Holdings LLC owned approximately 0.07% of Kimberly-Clark worth $31,811,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. William B. Walkup & Associates Inc. bought a new position in Kimberly-Clark during the second quarter valued at about $26,000. New Millennium Group LLC purchased a new position in Kimberly-Clark in the second quarter valued at approximately $28,000. Darwin Wealth Management LLC purchased a new stake in Kimberly-Clark in the third quarter worth $29,000. DiNuzzo Private Wealth Inc. increased its position in Kimberly-Clark by 808.0% in the third quarter. DiNuzzo Private Wealth Inc. now owns 227 shares of the company's stock worth $32,000 after buying an additional 202 shares during the last quarter. Finally, Kennebec Savings Bank purchased a new position in shares of Kimberly-Clark during the 3rd quarter valued at $36,000. Hedge funds and other institutional investors own 76.29% of the company's stock.
Insider Activity
In other Kimberly-Clark news, VP Andrew Drexler sold 3,000 shares of Kimberly-Clark stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $139.01, for a total value of $417,030.00. Following the transaction, the vice president now directly owns 5,053 shares of the company's stock, valued at $702,417.53. The trade was a 37.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.62% of the stock is owned by corporate insiders.
Kimberly-Clark Price Performance
Kimberly-Clark stock traded down $2.04 during mid-day trading on Tuesday, hitting $137.52. 1,002,933 shares of the company traded hands, compared to its average volume of 2,103,475. The stock has a fifty day moving average price of $138.46 and a 200-day moving average price of $139.33. The stock has a market cap of $45.86 billion, a price-to-earnings ratio of 18.10, a price-to-earnings-growth ratio of 2.92 and a beta of 0.40. Kimberly-Clark Co. has a one year low of $117.67 and a one year high of $149.30. The company has a debt-to-equity ratio of 4.77, a quick ratio of 0.55 and a current ratio of 0.83.
Kimberly-Clark (NYSE:KMB - Get Free Report) last released its earnings results on Tuesday, October 22nd. The company reported $1.83 EPS for the quarter, beating analysts' consensus estimates of $1.69 by $0.14. Kimberly-Clark had a return on equity of 198.59% and a net margin of 12.97%. The business had revenue of $4.95 billion for the quarter, compared to analysts' expectations of $5.06 billion. During the same quarter in the prior year, the firm earned $1.74 earnings per share. The firm's revenue was down 3.5% on a year-over-year basis. On average, equities analysts predict that Kimberly-Clark Co. will post 7.27 earnings per share for the current fiscal year.
Kimberly-Clark Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Stockholders of record on Friday, December 6th will be issued a $1.22 dividend. The ex-dividend date is Friday, December 6th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.55%. Kimberly-Clark's payout ratio is 63.29%.
Analyst Ratings Changes
Several equities research analysts recently weighed in on KMB shares. Barclays boosted their price objective on Kimberly-Clark from $135.00 to $144.00 and gave the company an "equal weight" rating in a research note on Friday, October 11th. Royal Bank of Canada restated an "outperform" rating and set a $165.00 price target on shares of Kimberly-Clark in a research note on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Kimberly-Clark from $146.00 to $147.00 and gave the company a "hold" rating in a research note on Tuesday, October 8th. UBS Group dropped their target price on Kimberly-Clark from $153.00 to $151.00 and set a "neutral" rating on the stock in a research report on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. reduced their price target on Kimberly-Clark from $142.00 to $140.00 and set an "underweight" rating for the company in a research report on Wednesday, October 23rd. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $149.93.
View Our Latest Stock Analysis on Kimberly-Clark
About Kimberly-Clark
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Stories
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.